Hormone Therapy and Risk of Ovarian Cancer

激素治疗和卵巢癌的风险

• 批准号: 6999264
• 负责人: ANNA H. WU
• 金额: $ 22.21万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6999264
• 关键词: DNA; body physical characteristic; cancer risk; combination chemotherapy; dosage; epithelium; estrogens; genetic susceptibility; histology; hormone metabolism; hormone therapy; human data; human genetic material tag; human middle age (35-64); human old age (65+); human subject; longitudinal human study; neoplasm /cancer epidemiology; neoplasm /cancer invasiveness; ovary neoplasms; patient oriented research; progestins; single nucleotide polymorphism; therapy adverse effect; women' s health; DNA; body physical characteristic; cancer risk; combination chemotherapy; dosage; epithelium; estrogens; genetic susceptibility; histology; hormone metabolism; hormone therapy; human data; human genetic material tag; human middle age (35-64); human old age (65+); human subject; longitudinal human study; neoplasm /cancer epidemiology; neoplasm /cancer invasiveness; ovary neoplasms; patient oriented research; progestins; single nucleotide polymorphism; therapy adverse effect; women' s health

暂无数据